Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Cancer research and Gene knockdown, with related work in HeLa, Competing endogenous RNA, Calcitriol receptor. Notable publications include 'LncRNA HOXA11‐AS drives cisplatin resistance of human LUAD cells via modulating miR‐454‐3p/Stat3', 'Expressions of vitamin D metabolic components VDBP, CYP2R1, CYP27B1, CYP24A1, and VDR in placentas from normal and preeclamptic pregnancies', and 'Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis'.
SLC7A5-ERBB2 axis drives olaparib resistance via de novo lipid synthesis in ovarian cancer
Multifunctionality of angiosperm floral bracts: a review
ZNF146 regulates cell cycle progression via TFDP1 and DEPDC1B in ovarian cancer cells
SAA suppresses α-PD-1 induced anti-tumor immunity by driving TH2 polarization in lung adenocarcinoma
Noninvasive early differential diagnosis and progression monitoring of ovarian cancer using the copy number alterations of plasma cell-free DNA
Patterns and drivers of plant sexual systems in the dry-hot valley region of southwestern China
GBAS Regulates the Proliferation and Metastasis of Ovarian Cancer Cells by Combining with eEF1A1
Knockdown of TRIM44 inhibits the progression of ovarian cancer and is related to the FOXM1-EZH2 signaling pathway
Nab-Paclitaxel is Far Superior to Traditional Paclitaxel
<p>Serum Platelet-Derived Growth Factor Is Significantly Lower in Patients with Lung Cancer and Continued to Decrease After Platinum-Based Chemotherapy</p>
<p>Evaluation of p16 in Epithelial Ovarian Cancer for a 10-Year Study in Northeast China: Significance of HPV in Correlation with PD-L1 Expression</p>
Correlation between reticulum ribosome-binding protein 1 (RRBP1) overexpression and prognosis in cervical squamous cell carcinoma
Correlation between reticulum ribosome-binding protein 1 (RRBP1) overexpression and prognosis in cervical squamous cell carcinoma
Apatinib exerts anti-tumour effects on ovarian cancer cells
RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma
Expression of RRBP1 in epithelial ovarian cancer and its clinical significance
LncRNA HOXA11‐AS drives cisplatin resistance of human LUAD cells via modulating miR‐454‐3p/Stat3
Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis
Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer
Ellagic acid induces HeLa cell apoptosis via regulating signal transducer and activator of transcription 3 signaling
Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer
Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib‐resistant lung adenocarcinoma cells
High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome
The long non-coding RNA CRNDE promotes cervical cancer cell growth and metastasis
PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway
Nivolumab effectively inhibit platinum-resistant ovarian cancer cells via induction of cell apoptosis and inhibition of ADAM17 expression.
PubMed 2017cited by 23position: last
The clinical significance of HPIP and the associated prognosis in cervical cancer
S-l combined with cisplatin plus concurrent chemoradiotherapy versus cisplatin plus concurrent chemoradiotherapy for Chinese patients with advanced gastric cancer: a multi-centre randomized controlled trial
Down‐Regulation of <scp>TIMP</scp>3 Leads to Increase in <scp>TACE</scp> Expression and <scp>TNF</scp>α Production by Placental Trophoblast Cells
Researches and Advances of ADAM17 in Malignancy
Xiandai shengwu yixue jinzhan 2013cited by 0position: first